Comparative Effectiveness Research and the Environment for Health Care Decision-Making
This article was originally published in RPM Report
Executive Summary
During the last five years, there has beenenormous changes in the health care environment: the implementation of the Affordable Care Act and its many provisions, including the creation of PCORI; the development of health exchanges and a move toward value-based payments, most notably in Medicare programs. In the midst of all this change, what impact will comparative effectiveness research have on health care decision-making?
You may also be interested in...
Impact of CER Still on the Horizon, Say Health Care Stakeholders
CER remains very visible on an as-yet unattainable horizon as a source for medical treatment evidence. That’s the picture from the National Pharmaceutical Council’s fourth year of surveying health care stakeholders on comparative effectiveness research.
CER “Substantial Impact” Expected in Three-to-Five Years: NPC’s Annual Comparative Effectiveness Survey
CER is slowly beginning to enter the public lexicon. Respondents to the National Pharmaceutical Council annual survey on comparative effectiveness report being more familiar with CER now than two years ago; but they still see the major impact several years away – not right on the horizon.
The State of CER: Some Progress, Cautious Optimism
It isn’t a household name—yet—but the Patient-Centered Outcomes Research Institute has certainly increased its name recognition among health care stakeholders during the last year, especially as it works to meet the federally mandated requirements of the Affordable Care Act. This was just one of the findings by the National Pharmaceutical Council from the second year of surveying key stakeholders about comparative effectiveness research (CER) perceptions and its impact on health care decisions.